SNAP-8 (10mg)
Specifiche tecniche
| Purezza (HPLC) | ≥95% (HPLC) |
| Numero CAS | 868844-74-0 |
| Forma | White lyophilized powder |
| Conservazione | -20°C |
| Sequenza | Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂ |
| Peso molecolare | 1,075.17 g/mol |
| Forma salina | Acetate |
| Solubilità | Soluble in water |
SNAP-8 (10mg)
Prezzo di listino EUR · HU, SK, CZ, PL
- Eurozone (EUR)81,00 EUR
- Ungheria (HU)81,00 EUR≈ 32 400 Ft
- Slovacchia (SK)81,00 EUR
- Cechia (CZ)81,00 EUR≈ 2 025 Kč
- Polonia (PL)81,00 EUR≈ 344,25 zł
Stesso prezzo di listino in EUR per consegna in Ungheria, Slovacchia, Repubblica Ceca e Polonia. Pagamento in EUR.
HUF/CZK/PLN indicativi convertiti da EUR; la Slovacchia usa EUR. Tassi approssimativi. Pagamento in EUR.
Acetyl octapeptide-3 — SNAP-25 fragment for cosmetic muscle-contraction research. 10mg vial.
Solo per ricerca di laboratorio.
Non destinato al consumo umano, uso veterinario o diagnostico.
From the Peptide Explorer
An octapeptide that competes with SNAP-25 for incorporation into the SNARE complex, reducing neuromuscular junction signaling. As an extended version of Argireline (Acetyl Hexapeptide-3), SNAP-8 offers enhanced competition for the SNARE complex binding site.
Key Mechanisms
- ›SNARE complex disruption
- ›SNAP-25 competitive inhibition
- ›Reduced neurotransmitter vesicle fusion
- ›Topical muscle relaxation
- ›Expression line reduction
Primary Research Areas
- ›Expression wrinkle research
- ›Topical neuromodulation
- ›SNARE complex pharmacology
Key Research Findings
- Demonstrated SNARE complex disruption in vitro neurotransmission assays
- Reduced expression wrinkle depth by up to 63% in 28-day clinical study (topical)
- Enhanced activity compared to parent compound Argireline in competitive assays
Research Overview
An octapeptide that competes with SNAP-25 for incorporation into the SNARE complex, reducing neuromuscular junction signaling. As an extended version of Argireline (Acetyl Hexapeptide-3), SNAP-8 offers enhanced competition for the SNARE complex binding site.
Origin: Extended analog of SNAP-25 competitor Argireline (Acetyl Hexapeptide-3)
Mechanism of Action
- SNARE complex disruption
- SNAP-25 competitive inhibition
- Reduced neurotransmitter vesicle fusion
- Topical muscle relaxation
- Expression line reduction
Primary Research Areas
- Expression wrinkle research
- Topical neuromodulation
- SNARE complex pharmacology
Key Published Findings
- Demonstrated SNARE complex disruption in vitro neurotransmission assays
- Reduced expression wrinkle depth by up to 63% in 28-day clinical study (topical)
- Enhanced activity compared to parent compound Argireline in competitive assays
Research Protocol
Commonly studied routes: Topical. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
Room temperature in formulation
Important Notice
SNAP-8 (10mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Specifiche di ricerca
Synthesized for strict analytical consistency. Verified via HPLC/MS.Vedi standard qualità →
Manipolazione e conservazione
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water